Does Cholestyramine Light Interact with Levothyroxine And Liothyronine?
CDI records a major classification for Cholestyramine Light and Levothyroxine And Liothyronine. The stored summary is: Cholestyramine binds thyroid hormones in the intestine, impairing their absorption. Space administration by 4-5 hours. The mechanism involves binding of t4 and t3 in the intestine. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Major
- Cholestyramine Light Class
- Bile Acid Sequestrant
- Levothyroxine And Liothyronine Class
- l-Triiodothyronine
- Management
- Close medical supervision required
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Binding of T4 and T3 in the intestine
What To Tell Your Doctor or Pharmacist
If you are taking Cholestyramine Light and your doctor is considering prescribing Levothyroxine And Liothyronine (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask how frequently you should be monitored while these are co-prescribed
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider